Pharmacy Staffing Shortages Lead to Disruptions in Patient Care
Drug Topics
AUGUST 25, 2023
A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.
August, 2023
469 
Rise of Third-Party Pharmacy Audits
Drug Topics
AUGUST 24, 2023
A greater number of pharmacy audits are originating not only from third party payors, but also from various government agencies, such as Medicare and Medicaid.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opioid Settlement May Spur Cannabis as Potential New Pharmacy Revenue Stream
Pharmacy Times
AUGUST 30, 2023
The opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.
‘We need to do better:’ A biotech CEO on standing apart from the crowd
PharmaVoice
AUGUST 29, 2023
The CEO of Cullinan Oncology is taking a small biotech to the next step and believes the temporary financial barriers are smaller than scientific progress.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Antimicrobial Stewardship in Turkey – A Clinical Pharmacist’s Perspective
IDStewardship
AUGUST 1, 2023
In this article, a pharmacist from Turkey with advanced training in the area of infectious diseases provides insights on antimicrobial stewardship in Turkey. Interview with: Emre Kara, MSc., Ph.D. Interviewer: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 1 August 2023 A man colonized with extensively drug resistant Acinetobacter baumannii gets on a plane.
STAT+: One dose of psilocybin may have lasting effects on major depression, study finds
STAT
AUGUST 31, 2023
A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association. Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Don’t Get Caught Up With a HIPAA Violation
Drug Topics
AUGUST 31, 2023
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
Revolutionizing Drug Development Through Artificial Intelligence, Machine Learning
Pharmacy Times
AUGUST 31, 2023
The seamless integration of artificial intelligence and machine learning has the potential to accelerate research and enhance efficiency in a new era of personalized medicine.
A rare disease research aims to tackle disability discrimination in new lawsuit
PharmaVoice
AUGUST 22, 2023
How a pediatric neurologist is advocating for herself and the disabled community in a legal battle with the Howard Hughes Medical Institute.
Amid shortage, FDA clears several generics of Takeda's popular ADHD drug Vyvanse
Fierce Pharma
AUGUST 30, 2023
After 16 years on the market, Takeda's blockbuster attention-deficit/hyperactivity disorder (ADHD) med Vyvanse has finally reached its patent cliff. | After 16 years on the market, Takeda's blockbuster ADHD med Vyvanse has finally reached its patent cliff. And the FDA's approval of several generics comes amid a U.S. shortage of the drug.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
No longer brushed off: A Minnesota clinic tries to rewrite medicine’s approach to miscarriage
STAT
AUGUST 31, 2023
WOODBURY, Minn. — By the time Taylor Teske came to be sitting on an exam table in an obstetrician’s office in Minnesota, her medical records marked a devastating journey: nine pregnancies, one baby, eight miscarriages. The first miscarriage happened in June 2018, almost as soon as she found out she was pregnant. Teske told her boss at the vascular clinic where she worked that she was pregnant, and he asked if she wanted to sneak a look using the clinic’s ultrasound.
Humana launches in-home primary care through CenterWell
Fierce Healthcare
AUGUST 30, 2023
Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes. | Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes.
Why Should Independent Pharmacies Stock Pet Medications?
Drug Topics
AUGUST 29, 2023
Caring for pets is easier when a pharmacist is involved.
FDA Approves 0.9% Sodium Chloride Injection in 10, 20 mL Single-Dose Vials
Pharmacy Times
AUGUST 30, 2023
Sodium chloride injection contains sodium chloride in water and is administered intravenously, which is intended for a single-dose injection to replenish fluids and electrolytes.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Brii Biosciences aims to come up big where Sage and Biogen fell short
PharmaVoice
AUGUST 21, 2023
The depression space recently got a stinging FDA rebuke — but Brii thinks it can break through with improved formulations.
Amazon hikes free shipping minimum to $35 for non Prime members
Drug Store News
AUGUST 30, 2023
Non-Prime members previously have been required to spend $25 to qualify for free shipping.
Medicaid rebukes states for mistakenly disenrolling children
STAT
AUGUST 30, 2023
Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.
CMS suspects auto-renewal process at fault for wrongful Medicaid disenrollments
Fierce Healthcare
AUGUST 30, 2023
In a letter sent to all states (PDF), the Centers for Medicare & Medicaid Services ( | As more Medicaid beneficiaries are wrongly kicked off the program, CMS is requiring states to reevaluate its eligibility systems and auto-renewal process.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Filling Prescriptions for Pet Patients: Best Practices
Drug Topics
AUGUST 29, 2023
Filling prescriptions for animals is essentially the same as filling prescriptions for humans—with some key differences.
Researchers Find Increased Risk of Atrial Fibrillation After Menopause
Pharmacy Times
AUGUST 30, 2023
Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.
How an AstraZeneca exec is leading the charge in the next immuno-oncology era
PharmaVoice
AUGUST 17, 2023
The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.
Watch DSN: The Compliance Team touches on clinical services’ effect on pharmacy space
Drug Store News
AUGUST 30, 2023
At NACDS’ Total Store Expo, DSN caught up with The Compliance Team’s founder and CEO to discuss how clinical services are changing the retail pharmacy space.
STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum
STAT
AUGUST 31, 2023
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process. The American Hospital Association, the industry’s main lobbying group, told STAT it is “not commenting on this issue right now.
Providers can now see patients' insurance coverage in GoodRx's cost comparison tool
Fierce Healthcare
AUGUST 30, 2023
GoodRx has launched a new feature to allow healthcare professionals to see the cost of a patient’s prescription with their insurance. | The feature, embedded in GoodRx's provider solution, surfaces a patient’s coverage and benefits at the point of care with the goal of increasing price transparency and access to drugs.
Cannabis Effective at Reducing Symptoms in Children With Cancer, but More Research Needed
Drug Topics
AUGUST 28, 2023
A recent systematic review found no serious adverse events related to the use of cannabis for the management of cancer-related symptoms in children.
Upcoming Phase 3 Clinical Program Will Examine Efficacy of Oral PCSK9 Inhibitor MK-0616 in Patients With Hypercholesterolemia
Pharmacy Times
AUGUST 30, 2023
The phase 3 clinical program, CORALreef, consists of 3 trials and is likely the first of its kind for an oral PCSK9 inhibitor, according to the study authors.
Demand for weight loss drugs soars to nearly half of Americans
PharmaVoice
AUGUST 15, 2023
Drugs like the buzzy Ozempic are high on consumers’ radar — but lofty barriers to access remain.
Walmart kicks off Testing and Treatment Program at pharmacies in 12 states
Drug Store News
AUGUST 30, 2023
Under the program, Walmart pharmacists will test and treat customers for strep throat, flu and COVID-19.
STAT+: Departing Stanford president retracts two widely cited papers, against lead author’s wishes
STAT
AUGUST 31, 2023
After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne , the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.
How behavioral health app BeMe is aiming to connect with teens
Fierce Healthcare
AUGUST 30, 2023
In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. | In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. Amd according to new research, this methodology is proving successful.
FDA Delays Drug Supply Chain Security Act Deadline Until November 2024
Drug Topics
AUGUST 25, 2023
The new deadline to be in compliance with the requirements will be November 27, 2024.
FDA Approves Luspatercept-aamt for First-Line Treatment of Anemia in Adults With Lower-Risk Myelodysplastic Syndromes
Pharmacy Times
AUGUST 29, 2023
Luspatercept-aamt (Reblozyl) approved to treat adults with very low- to intermediate-risk myelodysplastic syndrome who may require regular red blood cell transfusions.
What pharma companies are getting wrong about drug repositioning
PharmaVoice
AUGUST 9, 2023
Children’s Tumor Foundation president Annette Bakker is working to teach the industry the crucial difference between drug repurposing and drug repositioning.
Let's personalize your content